Geron's the Biotech of the Day

Geron’s the Biotech of the Day Geron saw its shares rise $1.72, or 25%, to $8.68 after the company said it has received a patent that could be used in stem-cell research. The process would be used, if it’s ever needed, to provide an additional level of safety for cell therapies made from human embryonic […]


Geron’s the Biotech of the Day

Geron’s the Biotech of the Day Geron saw its shares rise $1.72, or 25%, to $8.68 after the company said it has received a patent that could be used in stem-cell research. The process would be used, if it’s ever needed, to provide an additional level of safety for cell therapies made from human embryonic […]


Genentech's Next Move

Genentech’s Next Move Genentech stunned the cancer world last week with news that its Avastin colon cancer drug extended patients’ lives by five months, proving wrong skeptics who said the blood vessel-blocking drug would never work. Now the biotech pioneer is embarking on a bold strategy to dominate the cancer drug market for decades to […]


Genentech’s Next Move

Genentech’s Next Move Genentech stunned the cancer world last week with news that its Avastin colon cancer drug extended patients’ lives by five months, proving wrong skeptics who said the blood vessel-blocking drug would never work. Now the biotech pioneer is embarking on a bold strategy to dominate the cancer drug market for decades to […]


GM crops 'good for developing countries'

GM crops ‘good for developing countries’ In a discussion paper out on Tuesday to coincide with a national GM debate in the UK, the influential Nuffield Council on Bio-ethics says the technology has the potential to increase crop yields and improve the livelihoods of poor people.


GM crops ‘good for developing countries’

GM crops ‘good for developing countries’ In a discussion paper out on Tuesday to coincide with a national GM debate in the UK, the influential Nuffield Council on Bio-ethics says the technology has the potential to increase crop yields and improve the livelihoods of poor people.


BIOTECH RALLIES

BIOTECH RALLIES The promise of new cancer therapies coming out of last week’s American Society of Clinical Oncology meeting in Chicago has helped restore vigor to the biopharmaceutical industry. It has also gotten a boost from a spate of new product approvals and generally upbeat earnings reports this year.


Do NOT follow this link or you will be banned from the site!
%d bloggers like this: